Perinatal risk factors for the neonatal abstinence syndrome in infants born to women on methadone maintenance therapy

Australian and New Zealand Journal of Obstetrics and Gynaecology

Volumn 50, Issue 3, 2010, Pages 253-258

  Liu, Anthony J W ^a   Jones, Michael P ^b   Murray, Henry ^c   Cook, Colleen Maree ^a   Nanan, Ralph ^a  

^a UNIVERSITY OF SYDNEY   (Australia)

^b MACQUARIE UNIVERSITY   (Australia)

^c NEPEAN HOSPITAL   (Australia)

Author keywords

Neonatal abstinence syndrome; Risk factors; Substance related disorders

Indexed keywords

MORPHINE; METHADONE; NARCOTIC AGENT;

ADULT; ARTICLE; CESAREAN SECTION; CORRELATION ANALYSIS; EXTERNAL VALIDITY; FEMALE; GESTATIONAL AGE; HUMAN; INFANT; INTERNAL VALIDITY; MAJOR CLINICAL STUDY; MEDICAL RECORD REVIEW; METHADONE TREATMENT; PERINATAL DRUG EXPOSURE; PREGNANCY; PRIORITY JOURNAL; RECEIVER OPERATING CHARACTERISTIC; RETROSPECTIVE STUDY; RISK FACTOR; VAGINAL DELIVERY; WITHDRAWAL SYNDROME; NEONATAL ABSTINENCE SYNDROME; NEWBORN; OPIOID-RELATED DISORDERS; PREGNANCY COMPLICATIONS; PRENATAL EXPOSURE; RISK ASSESSMENT; STATISTICAL MODEL; YOUNG ADULT;

ADULT; FEMALE; HUMANS; INFANT, NEWBORN; LOGISTIC MODELS; METHADONE; NARCOTICS; NEONATAL ABSTINENCE SYNDROME; OPIOID-RELATED DISORDERS; PREGNANCY; PREGNANCY COMPLICATIONS; PRENATAL EXPOSURE DELAYED EFFECTS; RETROSPECTIVE STUDIES; RISK ASSESSMENT; RISK FACTORS; YOUNG ADULT;

EID: 77953855481     PISSN: 00048666     EISSN: 1479828X     Source Type: Journal    
DOI: 10.1111/j.1479-828X.2010.01168.x     Document Type: Article

References (31)

1. Finnegan LP. Outcome of children born to women dependent on narcotics. In : Stimmel B, ed. The Effects of Maternal Alcohol and Drug Abuse on the Newborn. Adv Alcohol Subst Abuse. 1982 1 : 55 102.
2. Strauss ME, Andresko M, Stryker JC, Wardell JN, Dunkel LD. Methadone maintenance during pregnancy: Pregnancy, birth, and neonate characteristics. Am J Obstet Gynecol 1974 120 : 895 900.
3. van Baar AL, Fleury P, Soepatmi S, Ultee CA, Wesselman PJ. Neonatal behavior after drug dependent pregnancy. Arch Dis Child 1989 64 : 235 240. (Pubitemid 19053755)
4. Oei J, Feller JM, Lui K. Coordinated outpatient care of the narcotic-dependent infant. J Paediatr Child Health 2001 37 : 266 270.
5. Blinick G, Jerez E, Wallach RC. Methadone maintenance, pregnancy, and progeny. JAMA 1973 225 : 477 479.
6. Berghella V, Lim PJ, Hill MK, Cherpes J, Chennat J, Kaltenbach K. Maternal methadone dose and neonatal withdrawal. [see comment]. Am J Obstet Gynecol 2003 189 : 312 317.
7. Brown HL, Britton KA, Mahaffey D et al. Methadone maintenance in pregnancy: A reappraisal. Am J Obstet Gynecol 1998 179 : 459 463.
8. Dashe JS, Sheffield JS, Olscher DA, Todd SJ, Jackson GL, Wendel GD. Relationship between maternal methadone dosage and neonatal withdrawal. Obstet Gynecol 2002 100 : 1244 1249.
9. Doberczak TM, Kandall SR, Friedmann P. Relationship between maternal methadone dosage, maternal-neonatal methadone levels, and neonatal withdrawal. Obstet Gynecol 1993 81 : 936 940.
10. Dryden C, Young D, Hepburn M, Mactier H. Maternal methadone use in pregnancy: Factors associated with the development of neonatal abstinence syndrome and implications for healthcare resources. BJOG 2009 116 : 665 671.
11. Harper RG, Solish G, Feingold E et al. Maternal ingested methadone, body fluid methadone, and the neonatal withdrawal syndrome. Am J Obstet Gynecol 1977 129 : 417 424.
12. Lim S, Prasad MR, Samuels P et al. High-dose methadone in pregnant women and its effect on duration of neonatal abstinence syndrome. Am J Obstet Gynecol 2009 200 : 70.
13. Mack G, Thomas D, Giles W, Buchanan N. Methadone levels and neonatal withdrawal. J Paediatr Child Health 1991 27 : 96 100.
14. Madden JD, Chappel JN, Zuspan F et al. Observation and treatment of neonatal narcotic withdrawal. Am J Obstet Gynecol 1977 127 : 199 201.
15. McCarthy JJ, Leamon MH, Parr MS, Anania B. High-dose methadone maintenance in pregnancy: Maternal and neonatal outcomes. Am J Obstet Gynecol 2005 193 : 606 610.
16. McCarthy JJ, Leamon MH, Stenson G, Biles LA. Outcomes of neonates conceived on methadone maintenance therapy. J Subst Abuse Treat 2008 35 : 202 206.
17. Ostrea EM, Chavez CJ, Strauss ME. A study of factors that influence the severity of neonatal narcotic withdrawal. J Pediatr 1976 88 : 642 645.
18. Rosen TS, Pippenger CE. Pharmacologic observations on the neonatal withdrawal syndrome. J Pediatr 1976 88 : 1044 1048.
19. Strauss ME, Andresko M, Stryker JC, Wardell JN. Relationship of neonatal withdrawal to maternal methadone dose. Am J Drug Alcohol Abuse 1976 3 : 339 345.
20. Vinner E, Vignau J, Thibault D et al. Neonatal hair analysis contribution to establishing a gestational drug exposure profile and predicting a withdrawal syndrome. Ther Drug Monit 2003 25 : 421 432.
21. Australian Bureau of Statistics. Census of Population and Housing: Socio-Economic Indexes for Areas (SEIFA), 2006. Australia - Data only, Cat. no. 2033.0.55.001. [Accessed 20 January 2010.] Available from URL: http://www.ausstats.abs.gov.au/Ausstats/subscriber.nsf/0/ D51E2B1E6FB35F1ACA25741700117816/$File/2033055001-%20seifa, %20local%20government%20areas,%20data%20cube%20only,%202006.xls#'Table 1'!A1
22. NSW Department of Health, Intergovernmental Committee on Drugs, Ministerial Council on Drug Strategy. National Clinical Guidelines for the Management of Drug Use during Pregnancy, Birth and the Early Developmental Years of the Newborn.
23. D'Apolito K. Most prominent symptoms of withdrawal in polydrug-exposed infants. Tenn Nurse 2001 64 : 20.
24. Bleeker SE, Moll HA, Steyerberg EW et al. External validation is necessary in prediction research: A clinical example. J Clin Epidemiol 2003 56 : 826 832.
25. Doberczak TM, Kandall SR, Wilets I. Neonatal opiate abstinence syndrome in term and preterm infants. J Pediatr 1991 118 : 933 937.
26. Dysart K, Hsieh HC, Kaltenbach K et al. Sequela of preterm versus term infants born to mothers on a methadone maintenance program: Differential course of neonatal abstinence syndrome. J Perinat Med 2007 35 : 344 346.
27. Burns L, Mattick RP. Using population data to examine the prevalence and correlates of neonatal abstinence syndrome. Drug Alcohol Rev 2007 26 : 487 492.
28. Seligman NS, Salva N, Hayes EJ, Dysart KC, Pequignot EC, Baxter JK. Predicting length of treatment for neonatal abstinence syndrome in methadone-exposed neonates. Am J Obstet Gynecol 2008 199 : 396.
29. Pohjavuori M, Rovamo L, Laatikainen T et al. Stress of delivery and plasma endorphins and catecholamines in the newborn infant. Biol Res Pregnancy Perinatol 1986 7 : 1 5.
30. Vogl SE, Worda C, Egarter C et al. Mode of delivery is associated with maternal and fetal endocrine stress response. BJOG 2006 113 : 441 445.
31. Lainwala S, Brown ER, Weinschenk NP, Blackwell MT, Hagadorn JI. A retrospective study of length of hospital stay in infants treated for neonatal abstinence syndrome with methadone versus oral morphine preparations. Adv Neonatal Care 2005 5 : 265 272.